Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 2071.28 Million | USD 3529.22 Million | 6.1% | 2023 |
The global Quinine Market size was worth around USD 2071.28 million in 2023 and is predicted to grow to around USD 3529.22 million by 2032 with a compound annual growth rate (CAGR) of roughly 6.1% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD million). The report covers a forecast and an analysis of the Quinine Market on a global and regional level.
Quinine is a drug used for the treatment of malaria and babesiosis. Quinine is used to treat malaria due to chloroquine-resistant Plasmodium falciparum when artesunate is not available. Although it is used for the syndrome of restless legs, it is not suggested for this purpose because of the danger of side effects. It can be used intravenously or by oral route. Resistance to quinine is observed in some parts of the globe. Quinine is also used in tonic water which imparts its bitter taste. Quinine was used after thoracoplasty to treat malaria and related febrile conditions, leg cramps triggered by vascular spasm, inner hemorrhoids, varicose veins, and pleural cavities.
Based on mode of administration, the quinine market is segmented into oral administration, intravenous administration, intramuscular administration and others. Among the mode of administration segment, intramuscular segment is most commonly used mode of administration.
Based on the application, the market is classified into antimalarial, antipyretic and others. The most dominant application segment is anti-malarial application in terms of revenue.
End user segment of quinine market is further divided into hospitals, clinics, ambulatory surgery centers, and others. Hospitals application segment dominated the market in terms of revenue in 2023 owing to more inclination of patients towards the hospitals.
Report Attributes | Report Details |
---|---|
Report Name | Quinine Market |
Market Size in 2023 | USD 2071.28 Million |
Market Forecast in 2032 | USD 3529.22 Million |
Growth Rate | CAGR of 6.1% |
Number of Pages | 110 |
Key Companies Covered | Alchem International, Van Wankum Ingredients, Arnold Suhr Qimpex, Vital Labs, Cosmos International, Chempro Pharma Private Limited |
Segments Covered | By Type, By end-user and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Geographically, in 2023, the Middle East and Africa dominated the quinine industry and will continue to develop considerably over the forecast period. High production cinchona, an increasing incidence of malaria, and an increasing amount of fever cases will cascade the development of the sector over the forecast period. Asia Pacific is anticipated to closely follow the trend. Asia Pacific is anticipated to see the greatest development during the forecast period as a result of rising healthcare spending, rising disposable revenue leading to increased affordability, and increasing patient tendency towards quinine derivatives. High population base in India, improved patient knowledge of malaria, and increased fever causing diseases will further increase market growth.
Some of the key players in quinine market include:
Global Quinine Market: Mode of Administration Segment Analysis
Global Quinine Market: Application Segment Analysis
Global Quinine Market: End User Segment Analysis
Global Quinine Market: Regional Segment Analysis
FrequentlyAsked Questions
Quinine is a drug used for the treatment of malaria and babesiosis. Quinine is used to treat malaria due to chloroquine-resistant Plasmodium falciparum when artesunate is not available.
According to study, the Quinine Market size was worth around USD 2071.28 million in 2023 and is predicted to grow to around USD 3529.22 million by 2032.
Asia Pacific has been leading the Quinine Market and is anticipated to continue on the dominant position in the years to come.
Asia Pacific has been leading the Quinine Market and is anticipated to continue on the dominant position in the years to come.
The Quinine Market is led by players like Alchem International, Van Wankum Ingredients, Arnold Suhr Qimpex, Vital Labs, Cosmos International, Chempro Pharma Private Limited.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed